My watch list
my.bionity.com  
Login  

Discovered a new therapeutic target for the treatment of Alzheimer's disease

The results of the study indicate that the levels of the protein SFRP1 are abnormally elevated in the brain and cerebrospinal fluid of Alzheimer's patients

16-Jul-2019

Experiments performed in mice, in which the main pathogenic markers of the disease have been evaluated, show that the progression of the disease is prevented when the function of this protein is inactivated.

Alzheimer's disease is characterized by a progressive and irreversible loss of cognitive abilities. "Treatment of the disease represents an unresolved challenge that needs alternative approaches to those currently on trial; there is need of new perspectives that take into account the complexity of the disease. Given its multifactorial origin, these new approaches should be designed against factors that act simultaneously in more than one of the pathological processes of the disease" explains Paola Bovolenta, CSIC researcher at the Molecular Biology Center 'Severo Ochoa' (Joint centre of the CSIC and the Autonomous University of Madrid).

This study identifies that the protein SFRP1 (Secreted Frizzled Related Protein 1) is one of those factors. SFRP1 acts in multiple processes and its elevated levels are pathogenic. "We believe that our results represent an innovation in the field of Alzheimer's disease. We demonstrate that the neutralization of SFRP1 could be a promising therapeutic alternative. This is something that we now need to explore in depth. We also believe that the measure of SFRP1 levels in the cerebrospinal fluid or in serum may represent a useful diagnostic marker in the future, "adds Pilar Esteve, co-responsible of the study and member of the Center for Molecular Biology Severo Ochoa '.

Facts, background information, dossiers
More about CSIC
  • News

    Honouring a pioneer of DNA testing

    The European Patent Office (EPO) announces that Spanish scientist and university professor Margarita Salas Falgueras has been nominated for the European Inventor Award 2019 for her pioneering invention that enables DNA tests to reconstruct full genomes from small samples such as a single ha ... more

    A plastic-eating caterpillar

    Generally speaking, plastic is incredibly resistant to breaking down. That's certainly true of the trillion polyethylene plastic bags that people use each and every year. But researchers reporting in Current Biology on April 24 may be on track to find a solution to plastic waste. The key is ... more

    Bigger, better, faster

    The molecular machine that makes essential components of ribosomes – the cell’s protein factories – is like a Swiss-army knife, researchers at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and the Centro de Investigaciones Biológicas in Madrid, Spain, have found. ... more

  • Research Institutes

    Consejo Superior De Investigaciones Científias (CSIC)

    The Spanish National Research Council (CSIC) is the largest public institution dedicated to research in Spain and the third largest in Europe. Belonging to the Spanish Ministry of Science and Innovation through the Secretary of State for Research, its main objective is to develop and promot ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE